Potent and specific human monoclonal antibodies against SARS-CoV-2 Omicron variant by rapid mRNA immunization of humanized mice
Ren, P.; Peng, L.; Fang, Z.; Suzuki, K.; Renauer, P. A.; Lin, Q.; Bai, M.; Yang, L.; Li, T.; Clark, P.; Klein, D.; Chen, S.
Show abstract
The Omicron variant (B.1.1.529) of SARS-CoV-2 rapidly becomes dominant globally. Its extensive mutations confer severe efficacy reduction to most of existing antibodies or vaccines. Here, we developed RAMIHM, a highly efficient strategy to generate fully human monoclonal antibodies (mAbs), directly applied it with Omicron-mRNA immunization, and isolated three potent and specific clones against Omicron. Rapid mRNA immunization elicited strong anti-Omicron antibody response in humanized mice, along with broader anti-coronavirus activity. Customized single cell BCR sequencing mapped the clonal repertoires. Top-ranked clones collectively from peripheral blood, plasma B and memory B cell populations showed high rate of Omicron-specificity (93.3%) from RAMIHM-scBCRseq. Clone-screening identified three highly potent neutralizing antibodies that have low nanomolar affinity for Omicron RBD, and low ng/mL level IC50 in neutralization, more potent than majority of currently approved or authorized clinical RBD-targeting mAbs. These lead mAbs are fully human and ready for downstream IND-enabling and/or translational studies.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Multivalency transforms SARS-CoV-2 antibodies into broad and ultrapotent neutralizers 95%
- A public antibody class recognizes a novel S2 epitope exposed on open conformations of SARS-CoV-2 spike 95%
- Cross-reactive serum and memory B cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection 95%
Similar papers in this journal
- Deep repertoire mining uncovers ultra-broad coronavirus neutralizing antibodies targeting multiple epitopes 96%
- Fortuitous Somatic Mutations during Antibody Evolution Endow Broad Neutralization against SARS-CoV-2 Omicron Variants 96%
- Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals 96%
Similar papers in this journal
- Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination 96%
- Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron subvariants BA.2, BA.2.12.1 and BA.5 94%
- Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages 94%
Similar papers in this journal
- MAAD: Multidimensional Antiviral Antibody Database 93%
- Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2 92%
- Single-dose AAV-based vaccine induces a high level of neutralizing antibodies against SARS-CoV-2 in rhesus macaques 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.